Reflections from IPPR’s new report launch – Bismarck versus Beveridge Revisited
Capital concerns I was in the room [...]
Agreement on pharmaceutical pricing between the United States and the United Kingdom
The UK and US governments have finalised [...]
ADHD Review: Interim findings lay bare the complexity of the ‘overdiagnosis’ debate
Amid growing debate around ADHD ‘overdiagnosis’, the [...]
NICE 2026: The goalposts have moved
Three to six months. That is the time saving [...]
Protected: The global awakening: How ADHD became the defining health system challenge of a generation
This content is password-protected. To view it, please enter the [...]
Transforming women’s healthcare: Lessons from Ireland
On International Women’s Day 2022 we launched Ireland’s first [...]
CF and Medlior Announce Strategic Partnership to Accelerate Multinational Real-World Evidence for Global Life Sciences Research
London, UK and Calgary, Canada – Medlior Health [...]
We have turned a corner: What the ARUK conference told us about the future of dementia treatment
The CF Life Sciences team attended the ARUK 2026 [...]
SEND Reform: Putting Children and Young People First
As part of the Department for Education's [...]
Inside the NHS’s National Cancer Plan for England 2026-2035
Cancer remains England's biggest killer, affecting 1 [...]
